Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 1366 results for "pharma"

Top five Sensex firms add Rs 31k cr in market valuation
Business Standard

Top five Sensex firms add Rs 31k cr in market valuation

TCS emerges as the biggest gainer; CIL, Infosys, HDFC Bank, SBI and Sun Pharma suffer losses Press Trust of India | New Delhi August 31, 2014 Last Updated at 10:45 IST The combined market valuation of five of the top-10 blue-chip Sensex companies surged by Rs ... Business Standard, 5 hours ago
Top six Sensex cos add nearly Rs 48k cr in market valuation The Financial Chronicle, 1 week ago

1,176 images for pharma

American Banking News, 1 day ago
Financial Express, 3 days ago
Financial Express, 2 days ago
American Banking News, 3 days ago
The Nation Pakistan, 3 days ago
ETurboNews, 2 days ago
Skokie Review, 22 hours ago
Deccan Chronicle, 3 days ago
Business Standard, 1 hour ago
Pharmaceutical Online, 15 hours ago

Bill & Melinda Gates Foundation: GAVI & PHFI help create incentives for pharma cos to make low-cost vaccines

The project used vaccines that are licensed in India and that have been administered safely around the world tens of millions of times, preventing countless cases of cervical cancer illness and death. Edited excerpts of replies by an India spokesperson of ...
 Economic Times11 hours ago
Business Standard

Natco Pharma's partner Mylan files for Copaxone generic

An Abbreviated New Drug Application (ANDA) for three-times-a-week generic Copaxone (glatiramer acetate injection) filed by Mylan Inc has been accepted by the US Food and Drug Administration (US FDA). According to a released issued by Natco Pharma ...
 Hindu Business Line22 hours ago Natco gets USFDA acceptance for generic Copaxone  Business Standard1 day ago NATCO PHARMA : marketing partner, Mylan Inc., files ANDA For Three Times Per Week Generic Copaxone® 40 mg/mL  4 Traders23 hours ago Natco Pharma's partner Mylan Inc files ANDA for generic Copaxone  Economic Times19 hours ago

BJP's Pharma Cell raised medical issues

Bharatiya Janata Party Chandigarh Pharma and Doctor Cell on Saturday held meeting with party's National Co-Convener of the BJP Dr Dinesh Upadhayayat at BJP Office Sector 33A.
 Times of India19 hours ago

IPCA Laboratories : Pharma cos may be hit by new price controls

Mumbai : The National Pharmaceutical Pricing Authority (NPPA) has fixed prices of ten combination drugs under Drugs Prices Control Order (DPCO), 2013. This is a part of a recent move taken by the NPPA to fix or revise prices in respect of 56 ...
 4 Traders22 hours ago Fresh drug price control rule may hit Indian pharmaceutical companies  DNA2 days ago Cancer Drugs Fund budget increased but pharma prices to be challenged  pharmaphorum2 days ago

EU grants orphan drug status to Innate Pharma's IPH4102 to treat cutaneous T-cell lymphoma

Innate Pharma SA, the innate immunity company developing first-in-class drug candidates for cancer and inflammatory diseases, announced that the European Commission has granted orphan drug designation to IPH4102 for the treatment of cutaneous T-cell ...
 PharmaBiz1 day ago Innate Pharma SA announces that the European Commission has granted orphan drug designation to IPH4102  Reuters UK3 days ago REG-INNATE PHARMA : ORPHAN DRUG DESIGNATION IN THE EUROPEAN UNION FOR IPH4102  Reuters4 days ago INNATE PHARMA : ORPHAN DRUG DESIGNATION IN THE EUROPEAN UNION FOR IPH4102  Virtual Strategy Magazine4 days ago
[x]  
American Banking News

Bio Blast Pharma EPS of -$0.10

ews Editor Bio Blast Pharma (NASDAQ:ORPN): Q2 EPS
 Seeking Alpha1 day ago Lexicon Pharma (LXRX) Files $150M Mixed Self  Town Hall1 day ago Arena Pharma (ARNA) Gets Orphan Status for PAH Treatment  TVNewsCheck1 day ago Enzymotec (ENZY) Names New CEO of VAYA Pharma; Adds Other Execs  TVNewsCheck1 day ago
[x]  
Sify

Pharma cos look up to solar power to stall power crisis impacting production plants

Bogged down by staggering power supply, pharma units across India and primarily in Karnataka are looking at renewable energy solutions like solar power to solve the crisis. The cancellation of the coal block allocation is another blow to power ...
 PharmaBiz1 day ago Stocks in news: ONGC, Adani Power, Torrent Pharma, MCX, ITD  Money Control3 days ago Sensex gains 76 points; GAIL up, Tata Power down  Myiris3 days ago Sensex drops 40 points; Nifty below 7,900 mark  Myiris5 days ago

Pharma-funded patients’ groups pushing industry agenda on biosimilars

Patients' groups with significant funding from pharma appear to back the multinational pharmaceutical industry's attempt to block the entry of cheaper copies of biological medicines which could help increase access of these medicines to patients across the ...
 Times of India1 day ago Pharma-funded patients groups pushing industry agenda on biosimilars  Big News Network23 hours ago Pharma-funded patients' groups pushing industry agenda on biosimilars  FirstWord Pharma1 day ago

High-market concentration in some molecules is major issue in Sun Pharma-Ranbaxy deal: CCI Chairman

The major issue being probed in the multi-billion dollar Sun Pharma-Ranbaxy deal is to see if there is a high-market concentration in some molecules which will emerge as result of the proposed merger and acquisition (M&A) deal, chairman of the ...
 Meri News1 day ago High-market concentration major issue in Sun Pharma-Ranbaxy deal: CCI chairman  Myiris1 day ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - pharma
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less